| S6871 |
Sodium oxamate
|
Sodium oxamate (SO, Aminooxoacetic acid, Oxamic acid) is an inhibitor of lactate dehydrogenase (LDH) that specificly inhibits LDH‑A. This compound induces G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway and promotes apoptosis through enhancement of mitochondrial ROS generation.
|
-
Adv Sci (Weinh), 2025, 12(8):e2411943
-
Nucleic Acids Res, 2025, 53(17)gkaf882
-
Cell Rep Med, 2025, 6(8):102292
|
|
| S0108 |
AZ-33
|
AZ-33 (LDHA Inhibitor 33) is a potent inhibitor of lactate dehydrogenase A (LDHA) with IC50 of 0.5 μM. LDHA is the key enzyme involved in anaerobic glycolysis which is frequently deregulated in human malignancies.
|
-
Frontiers in Molecular Biosciences, January 12, 2022, 806650
-
Research Square (Preprint), 2025, nan
-
Frontiers in Molecular Biosciences, 2022, 806650
|
|
| S8928 |
FX-11 (LDHA Inhibitor FX11)
|
FX-11(LDHA Inhibitor FX11) is a potent inhibitor of lactate dehydrogenase A (LDHA)) with IC50 of 49.27 μM in BxPc-3 cells.
|
-
Theranostics, 2025, 15(7):3055-3075
-
Cell Death Dis, 2025, 16(1):574
-
Cell Metab, 2024, S1550-4131(24)00415-7
|
|
| S9606 |
Galloflavin
|
Galloflavin (NSC 107022) is a novel inhibitor of lactate dehydrogenasee (LDH) with Ki values of 5.46 μM and 15.06 μM for LDH-A and LDH-B, respectively.
|
-
J Virol, 2024, 98(1):e0167023
-
Journal of Virology, 2024, e01670-23
-
Journal of Virology, 2024, e0167023
|
|
| E4772 |
LDHA-IN-3
|
LDHA-IN-3, a selenobenzene derivative, is a potent noncompetitive inhibitor of Lactate Dehydrogenase A (LDHA), with an IC50 of 145.2 nM. It exhibits significant anti-tumor activity, effectively reducing LDHA activity and lactate production under both normoxic and hypoxic conditions. It also induces mitochondria-mediated apoptosis through the generation of reactive oxygen species.
|
|
|
| E3731 |
Chinese Gallnut Extract
|
Chinese Gallnut Extract is obtained from Melaphis chinensis gallnut, which is the most potent inhibitor of human Lactate dehydrogenase (LDH)-A in the high-throughput screening study of 905 natural products.
|
|
|
| E6631New |
Oxamic acid
|
Oxamic acid (Oxamate) is a classical inhibitor of lactate dehydrogenase‑A (LDH‑A) that competitively blocks the conversion of pyruvate to lactate. It also induces G2/M arrest and apoptosis, and increases radiosensitivity in nasopharyngeal carcinoma cells.
|
|
|
| S6675 |
(R)-GNE-140
|
(R)-GNE-140 is an inhibitory agent for LDHA, LDHB, and LDHC, with IC50 values of 3 nM and 5 nM for LDHA and LDHB, respectively. (R)-GNE-140 is 18 times more potent than its S isomer.
|
-
J Clin Invest, 2024, 134(17)e177606
-
Nature Communications, 2024, 90
-
J Mol Cell Biol, 2024, mjae056
|
|
| S8590 |
GSK2837808A
|
GSK2837808A is a selective LDHA (lactate dehydrogenase A) inhibitor with IC50 of 2.6 nM and 43 nM for hLDHA and hLDHB, respectively.
|
-
Cancer Commun (Lond), 2025, 10.1002/cac2.70036
-
EMBO Rep, 2025, 10.1038/s44319-025-00573-8
-
Nat Neurosci, 2022, 25(7):865-875
|
|